Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase

Journal of Biological Chemistry

Volumn 278, Issue 34, 2003, Pages 31465-31468

  Lewandowicz, Andrzej ^a   Tyler, Peter C ^b   Evans, Gary B ^b   Furneaux, Richard H ^b   Schramm, Vern L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CALLAGHAN INNOVATION   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; IMMUNOLOGY; TISSUE;

ERYTHROCYTES;

ENZYMES;

4' DEAZA 1' AZA 2' DEOXY 1' (9 METHYLENE)IMMUCILLIN G; 4' DEAZA 1' AZA 2' DEOXY 1' (9 METHYLENE)IMMUCILLIN H; 8 AZAIMMUCILLIN H; ALLOPURINOL; COMPACTIN; IMMUCILLIN G; IMMUCILLIN H; METHOTREXATE; PENTOSTATIN; PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR; SPARFOSIC ACID; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME STRUCTURE; ERYTHROCYTE; GENETIC DISORDER; GRAFT REJECTION; IMMUNE DEFICIENCY; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE;

ENZYME INHIBITORS; HUMANS; PURINE-NUCLEOSIDE PHOSPHORYLASE;

ANIMALIA; BOVINAE;

EID: 0042357238     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.C300259200     Document Type: Article

References (30)

1. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R., and Diamond, L. K. (1975) Lancet 1, 1010-1013
2. Chan, T.-S. (1978) Cell 14, 523-530
3. Cohen, A., Gudas, L. J., Ammann, A. J., Staal, G. E. J., and Martin, D. E., Jr. (1978) J. Clin. Invest. 61, 1405-1409
4. Ullman, B., Clift, S. M., Gudas, L. J., Levinson, B. B., Wormsted, M. A., and Martin, D. E., Jr. (1980) J. Biol. Chem. 255, 8308-8314
5. Bantia, S., Ananth, S. L., Parker, C. D., Horn, L. L., and Upshaw, R. (2003) Int. Immunopharmacol. 3, 879-887
6. Mansson, E., Flordal, E., Lilemark, J., Spasokoukotskaja, T., Elford, H., Lagercrantz, S., Eriksson, S., and Albertioni, F. (2003) Biochem. Pharmacol. 65, 237-247
7. Osborne, W. R. (1980) J. Biol. Chem. 255, 7089-7092
8. Montgomery, J. A., Niwas, S., Rose, J. D., Secrist III, J. A., Babu, Y. S., Bugg, C. E., Erion, M. D., Guida, W. C., and Ealick, S. E. (1993) J. Med. Chem. 36, 55-69
9. Duvic, M., Olsen, E. A., Omura, G. A., Maize, J. C., Vonderheid, E. C., Elmets, C. A., Shupack, J. L., Demierre, M. F., Kuzel, T. M., and Sanders, D. Y. (2001) J. Am. Acad. Dermatol. 44, 940-947
10. Kline, P. C., and Schramm, V. L. (1995) Biochemistry 34, 1153-1162
11. Miles, R. W., Tyler, P. C., Furneaux, R. H., Bagdassarian, C. K., and Schramm, V. L. (1998) Biochemistry 37, 8615-8621
12. Kicska, G. A., Long, L., Hörig, H., Fairchild, C., Tyler, P. C., Furneaux, R. H., Schramm, V. L., and Kaufman, H. L. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 4593-4598
13. Banti, S., Miller, P. J., Parker, C. D., Ananth, S. L., Horn, L. L., Babu, Y. S., and Sadhu J. S. (2002) Int. Immunopharmacol. 2, 913-923
14. Kilpatrick, J. M., Morris, P. E., Serota, D. G., Jr., Phillips, D., Moore, D. R., Bennett, J. C., and Babu, Y. S. (2003) Int. Immunopharmacol. 3, 541-548
15. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Kim, K., and Schramm, V. L. (2002) J. Biol. Chem. 277, 3219-3225
16. McIvor, R. S., Goddar, J. M., Simones, C. C., and Martin, D. W., Jr. (1985) Mol. Cell Biol. 5, 1349-1357
17. Evans, G. B., Furneaux, R. H., Gainsford, G. J., Schramm, V. L., and Tyler, P. C. (2000) Tetrahedron 56, 3053-3062
18. Evans, G. B., Furneaux, R. H., Lewandowicz, A., Schramm, V. L., and Tyler, P. C. (2003) J. Med. Chem., 46, 3412-3423
19. Schramm, V. L., and Tyler, P. C. (2003) Curr. Top. Med. Chem. 3, 525-540
20. Lewandowicz, A., Shi, W., Evans, G. B., Tyler, P. C., Furneaux, R. H., Basso, L. A., Santos, D. S., Almo, S. C., and Schramm, V. L. (2003) Biochemistry 42, 6057-6066
21. Kim, B. K., Cha, S., and Parks, R. E., Jr. (1968) J. Biol. Chem. 243, 1771-1776
22. Morrison, J. F., and Walsh, C. T. (1988) Adv. Enzymol. Relat. Areas. Mol. Biol. 61, 201-301
23. Mao, C., Cook, W. J., Zhou, M., Federov, A. A., Almo, S. C., and Ealick, S. E. (1998) Biochemistry 37, 7135-7146
24. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Shi, W., Fedorov, A., Lewandowicz, A., Cahill, S. M., Almo, S. C., and Schramm, V. L. (2002) Biochemistry 41, 14489-14498
25. Sauve, A. A., Cahill, S. M., Zech, S. G., Basso, L. A., Lewandowicz, A., Santos, D. S., Grubmeyer, C., Evans, G. B., Furneaux, R. H., Tyler, P. C., McDermott, A., Girvin, M. E., and Schramm, V. L. (2003) Biochemistry 42, 5694-5705
26. Berti, P. J., and Tanaka, K. S. E. (2002) Adv. Phys. Org. Chem. 37, 239-314
27. Jiang, Y. L., Ichikawa, Y., and Stivers, J. T. (2002) Biochemistry 41, 7116-7124
28. Fedorov, A., Shi, W., Kicska, G., Fedorov, E., Tyler, P. C., Furneaux, R. H., Hanson, J. C., Gainsford, G. J., Larese, J. Z., Schramm, V. L., and Almo, S. C. (2001) Biochemistry 40, 853-860
29. Bantia, S., Miller, P. J., Parker, C. D., Ananth, S. L., Horn, L. L., Kilpatrick, J. M., Morris, P. E., Hutchison, T. L., Montgomery, J. A., and Sandhu, J. S. (2001) Int. Immunopharmacol. 1, 1199-1210
30. Gad, S. C., and Chengelis, C. P. (1992) Animal Models of Toxicology, p. 168, Marcel Dekker, New York